Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70436-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70436-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg-30ct (150mg 30ct)

150mg-30ct (150mg 30ct)
Label for Bupropion Hydrochloride XL 150 mg extended-release tablets by Slate Run Pharmaceuticals, LLC. The oral tablet is for once-daily use with a package count of 30 tablets. The label includes a warning about not using with ZYBAN or drugs containing bupropion hydrochloride and storage instructions. The label shows the NDC 70436-010-04 and the labeler information including manufacturing details.*
FDA Label Image

150mg-500ct (150mg 500ct)

150mg-500ct (150mg 500ct)
Label text for Bupropion Hydrochloride XL Extended-Release Tablets 150 mg by Slate Run Pharmaceuticals. Includes dosage form, strength, a warning against use with Zyban or other bupropion products, pharmacist dispensing instructions, storage conditions, and manufacturer details.*
FDA Label Image

150mg-90ct (150mg 90ct)

150mg-90ct (150mg 90ct)
The label for Bupropion Hydrochloride XL 150 mg extended-release tablets, USP (XL) by Slate Run Pharmaceuticals, LLC. It is a 90-tablet package intended for once-daily oral administration. The label includes a warning against use with ZYBAN or similar products containing bupropion hydrochloride and advises dispensing the Medication Guide separately. Additional sections provide storage instructions, dosage information, trademark acknowledgment, manufacturer details, and a barcode.*
FDA Label Image

300mg-30ct (300mg 30ct)

300mg-30ct (300mg 30ct)
Label of Bupropion Hydrochloride XL 300 mg extended-release tablets by Slate Run Pharmaceuticals, LLC. The label states it is for once-daily oral use, contains 30 coated tablets, and includes a warning about not using with ZYBAN or other bupropion products. Storage and dispensing instructions, lot/serialization area, and a barcode are also visible.*
FDA Label Image

300mg-500ct (300mg 500ct)

300mg-500ct (300mg 500ct)
Bupropion Hydrochloride XL 300 mg extended-release tablets packaging label by Slate Run Pharmaceuticals, LLC. The label indicates once-daily oral tablets, warning against use with ZYBAN or medicines containing bupropion. It includes storage instructions, handling precautions, NDC 70436-011-02, and states the package contains 500 tablets. The manufacturer is Yichang Humanwell Oral Solid Dosage Plant in China.*
FDA Label Image

300mg-90ct (300mg 90ct)

300mg-90ct (300mg 90ct)
The packaging label for Bupropion Hydrochloride XL extended-release tablets shows a 300 mg strength oral tablet form. It is a once-daily prescription drug by Slate Run Pharmaceuticals. The label warns against use with products containing bupropion hydrochloride like ZYBAN. The container holds 90 tablets and includes storage instructions, manufacturer information, and a barcode. There is a coating-free area for lot and serialization data.*
FDA Label Image

Bupropion-structure (Bupropion Structure)

Bupropion-structure (Bupropion Structure)
Chemical structure of bupropion hydrochloride, showing the molecular arrangement including a chlorophenyl group, a ketone functional group, and a tert-butyl amine moiety with associated hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.